Literature DB >> 19543209

The associations of LPIN1 gene expression in adipose tissue with metabolic phenotypes in the Chinese population.

Yi-Cheng Chang1, Ling-Yin Chang, Tien-Jyun Chang, Yi-Der Jiang, Kuan-Ching Lee, Shan-Shan Kuo, Wei-Jei Lee, Lee-Ming Chuang.   

Abstract

The LPIN1 gene, encoding lipin-1 protein, plays critical roles in adipocyte differentiation and lipid metabolism. This study aimed to analyze the association of LPIN1 mRNA levels in human adipose tissue with metabolic phenotypes. We also examined the association of LPIN1 genetic variation with type 2 diabetes and related metabolic phenotypes in the Chinese population. The relative LPIN1 mRNA levels were measured in abdominal visceral (VAT) and subcutaneous adipose tissue (SAT) obtained from 102 nondiabetic Chinese females. Seven single-nucleotide polymorphisms (SNPs) spanning from the 5'-upstream region to the 3'-end of the LPIN1 gene were genotyped in 1,520 Chinese (760 type 2 diabetic cases and 760 controls). LPIN1 mRNA levels in VAT were negatively correlated with BMI (r = -0.21, P = 0.03), body fat percentage (r = -0.22, P = 0.02), plasma triglycerides levels (r = -0.21, P = 0.03), and plasma leptin levels (r = -0.63, P = 0.0002). LPIN1 mRNA levels were positively correlated with PPARG and ADIPOQ mRNA levels in both VAT and SAT. No single SNP of the LPIN1 gene was associated with type 2 diabetes in our population. One rare haplotype showed a significant association with type 2 diabetes (odds ratio (OR), 4.35; 95% confidence interval, 1.86-11.75; P = 4 x 10(-4)). No SNP or haplotype of the LPIN1 gene was associated with quantitative metabolic traits in the nondiabetic subjects. The results confirmed the association of LPIN1 gene expression in adipose tissue with lower adiposity and favorable metabolic profiles in the Chinese population. However, the LPIN1 gene seemed not to be a major susceptibility gene for type 2 diabetes or related metabolic phenotypes in the Chinese population.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19543209     DOI: 10.1038/oby.2009.198

Source DB:  PubMed          Journal:  Obesity (Silver Spring)        ISSN: 1930-7381            Impact factor:   5.002


  7 in total

Review 1.  Lipins: multifunctional lipid metabolism proteins.

Authors:  Lauren S Csaki; Karen Reue
Journal:  Annu Rev Nutr       Date:  2010-08-21       Impact factor: 11.848

2.  Gene structure and spatio-temporal expression of chicken LPIN2.

Authors:  Caixia Zhang; Runzhi Wang; Wen Chen; Xiangtao Kang; Yanqun Huang; Richard Walker; Juan Mo
Journal:  Mol Biol Rep       Date:  2014-02-22       Impact factor: 2.316

Review 3.  Lipins, lipinopathies, and the modulation of cellular lipid storage and signaling.

Authors:  Lauren S Csaki; Jennifer R Dwyer; Loren G Fong; Peter Tontonoz; Stephen G Young; Karen Reue
Journal:  Prog Lipid Res       Date:  2013-04-17       Impact factor: 16.195

4.  Molecular analysis of LPIN1 in Jordanian patients with rhabdomyolysis.

Authors:  Saied A Jaradat; Wajdi Amayreh; Kefah Al-Qa'qa'; Jan Krayyem
Journal:  Meta Gene       Date:  2015-12-22

5.  Micro-ribonucleic acid-binding site variants of type 2 diabetes candidate loci predispose to gestational diabetes mellitus in Chinese Han women.

Authors:  Xiaojing Wang; Wei Li; Liangkun Ma; Fan Ping; Juntao Liu; Xueyan Wu; Jiangfeng Mao; Xi Wang; Min Nie
Journal:  J Diabetes Investig       Date:  2018-03-02       Impact factor: 4.232

6.  Adipose-Specific Lipin-1 Overexpression Renders Hepatic Ferroptosis and Exacerbates Alcoholic Steatohepatitis in Mice.

Authors:  Zhou Zhou; Ting Jie Ye; Gregory Bonavita; Michael Daniels; Noah Kainrad; Alvin Jogasuria; Min You
Journal:  Hepatol Commun       Date:  2019-03-12

7.  Comparative Analyses of QTLs Influencing Obesity and Metabolic Phenotypes in Pigs and Humans.

Authors:  Sameer D Pant; Peter Karlskov-Mortensen; Mette J Jacobsen; Susanna Cirera; Lisette J A Kogelman; Camilla S Bruun; Thomas Mark; Claus B Jørgensen; Niels Grarup; Emil V R Appel; Ehm A A Galjatovic; Torben Hansen; Oluf Pedersen; Maryse Guerin; Thierry Huby; Philipppe Lesnik; Theo H E Meuwissen; Haja N Kadarmideen; Merete Fredholm
Journal:  PLoS One       Date:  2015-09-08       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.